NCT06833606

Brief Summary

The goal of this observational study is to evaluate the diagnostic ability of the main criteria currently adopted for the diagnosis of placenta accreta and to define the maternal outcomes in terms of complications of the different management strategies currently adoptable when placental accretism is suspected.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P25-P50 for all trials

Timeline
8mo left

Started Jul 2023

Typical duration for all trials

Geographic Reach
1 country

7 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress81%
Jul 2023Dec 2026

Study Start

First participant enrolled

July 17, 2023

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

December 3, 2024

Completed
3 months until next milestone

First Posted

Study publicly available on registry

February 19, 2025

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

February 19, 2025

Status Verified

October 1, 2024

Enrollment Period

3.5 years

First QC Date

December 3, 2024

Last Update Submit

February 11, 2025

Conditions

Keywords

diagnosis

Outcome Measures

Primary Outcomes (1)

  • Frequency of correspondence between prenatal diagnosis and intra-operative finding of placental accretism

    disappearance of the hypoecogenaretroplacental stria, lacunae placental vasculature, hypervascularization of the utero-vesical interface, interruption/irregularity of the bladder will be assessed by ultrasound

    Up to 1 month post-partum

Secondary Outcomes (1)

  • Frequency of maternal complications (Surgical site infection)

    Up to 1 month post-partum

Eligibility Criteria

Age18 Years - 44 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Patients with suspected placental accretism/percretism followed at the Outpatient Clinics of the Division of Obstetrics and Prenatal Age Medicine at IRCCS-AOUBO Policlinico di Sant'Orsola and participating centers.

You may qualify if:

  • Age between 18 years and 44 years
  • Pregnant women with suspected placental accretism
  • Acquisition of informed consent form

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (7)

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Bologna, Bologna, 40138, Italy

RECRUITING

Ospedale "M. Bufalini"

Cesena, Forlì-Cesena, 47521, Italy

RECRUITING

Ospedale "Morgagni-Pierantoni"

Forlì, Forlì-Cesena, 47121, Italy

RECRUITING

AOU Policlinico di Modena

Modena, Modena, 41100, Italy

RECRUITING

Azienda Ospedaliero - Universitaria di Parma

Parma, Parma, 43126, Italy

RECRUITING

Arcispedale Santa Maria Nuova

Reggio Emilia, Reggio Emilia, 42123, Italy

RECRUITING

Ospedale "Infermi" di Rimini

Rimini, Rimini, 47900, Italy

RECRUITING

MeSH Terms

Conditions

Placenta AccretaDisease

Condition Hierarchy (Ancestors)

Obstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesPlacenta DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Gianluigi Pilu, MD

    IRCCS Azienda Ospedaliero-Universitaria di Bologna

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Gianluigi Pilu, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 3, 2024

First Posted

February 19, 2025

Study Start

July 17, 2023

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

February 19, 2025

Record last verified: 2024-10

Locations